FBXW7 and acute lymphoblastic leukemia: In T-ALL cell lines, FBXW7 deficiency confers resistance to chemotherapy, which can be reversed by FBXW7 restoration or MCL-1 knockout, implicating that MCL-1 promotes FBXW7-deficient cells to escape from apoptosis (52, 53).